Pyxis Oncology, Inc.
USD3.19
+0.34 (+11.71%)
CEO
Thomas Civik
IPO Date
2021-10-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.49
Prev. Close
$2.86
Day Low
$2.44
Day High
$3.40
52W Low
$0.97
52W High
$5.55
Market Cap
$0.20B
Volume
4.92M
| -1.2 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -58.7% | -42.5% | 0.17 | 4.84 | -1.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -75.1% | -57.1% | 0.12 | 5.90 | -0.4 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -29.1% | -27.1% | 0.00 | 14.90 | -4.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 82.0% | -126.4% | -0.05 | 2.20 | -35.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 96.5% | -14.0% | -0.01 | 26.88 | -163.4 |
| -1.0 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -32.0% | -20.8% | 0.28 | 4.29 | -1.6 |
| 30 Jun 2025 | Q2 | 100.0% | -650.9% | -20.9% | -14.9% | 0.22 | 5.65 | -0.9 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -20.5% | -15.6% | 0.19 | 7.75 | -0.7 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -29.5% | -22.6% | 0.17 | 7.49 | -0.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -13.8% | -10.9% | 0.13 | 7.33 | -2.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -10.2% | -8.3% | 0.12 | 9.53 | -2.8 |
| 31 Mar 2024 | Q1 | 97.1% | -20.2% | -1.8% | -1.5% | 0.11 | 12.19 | -18.9 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -12.4% | -9.0% | 0.17 | 4.84 | -1.3 |